Literature DB >> 20203212

Prefrontal beta2 subunit-containing and alpha7 nicotinic acetylcholine receptors differentially control glutamatergic and cholinergic signaling.

Vinay Parikh1, Jinzhao Ji, Michael W Decker, Martin Sarter.   

Abstract

One-second-long increases in prefrontal cholinergic activity ("transients") were demonstrated previously to be necessary for the incorporation of cues into ongoing cognitive processes ("cue detection"). Nicotine and, more robustly, selective agonists at alpha4beta2* nicotinic acetylcholine receptors (nAChRs) enhance cue detection and attentional performance by augmenting prefrontal cholinergic activity. The present experiments determined the role of beta2-containing and alpha7 nAChRs in the generation of prefrontal cholinergic and glutamatergic transients in vivo. Transients were evoked by nicotine, the alpha4beta2* nAChR agonist ABT-089 [2-methyl-3-(2-(S)-pyrrolindinylmethoxy) pyridine dihydrochloride], or the alpha7 nAChR agonist A-582941 [2-methyl-5-(6-phenyl-pyridazin-3-yl)-octahydro-pyrrolo[3,4-c]pyrrole]. Transients were recorded in mice lacking beta2 or alpha7 nAChRs and in rats after removal of thalamic glutamatergic or midbrain dopaminergic inputs to prefrontal cortex. The main results indicate that stimulation of alpha4beta2* nAChRs evokes glutamate release and that the presence of thalamic afferents is necessary for the generation of cholinergic transients. ABT-089-evoked transients were completely abolished in mice lacking beta2* nAChRs. The amplitude, but not the decay rate, of nicotine-evoked transients was reduced by beta2* knock-out. Conversely, in mice lacking the alpha7 nAChR, the decay rate, but not the amplitude, of nicotine-evoked cholinergic and glutamatergic transients was attenuated. Substantiating the role of alpha7 nAChR in controlling the duration of release events, stimulation of alpha7 nAChR produced cholinergic transients that lasted 10- to 15-fold longer than those evoked by nicotine. alpha7 nAChR-evoked cholinergic transients are mediated in part by dopaminergic activity. Prefrontal alpha4beta2* nAChRs play a key role in evoking and facilitating the transient glutamatergic-cholinergic interactions that are necessary for cue detection and attentional performance.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20203212      PMCID: PMC2864641          DOI: 10.1523/JNEUROSCI.5712-09.2010

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  78 in total

1.  Effects of handling on extracellular levels of glutamate and other amino acids in various areas of the brain measured by microdialysis.

Authors:  W Timmerman; G Cisci; A Nap; J B de Vries; B H Westerink
Journal:  Brain Res       Date:  1999-07-03       Impact factor: 3.252

2.  Acute effects of the selective cholinergic channel activator (nicotinic agonist) ABT-418 in Alzheimer's disease.

Authors:  A Potter; J Corwin; J Lang; M Piasecki; R Lenox; P A Newhouse
Journal:  Psychopharmacology (Berl)       Date:  1999-03       Impact factor: 4.530

3.  Nicotinic stimulation produces multiple forms of increased glutamatergic synaptic transmission.

Authors:  K A Radcliffe; J A Dani
Journal:  J Neurosci       Date:  1998-09-15       Impact factor: 6.167

4.  Effect sizes and p values: what should be reported and what should be replicated?

Authors:  A G Greenwald; R Gonzalez; R J Harris; D Guthrie
Journal:  Psychophysiology       Date:  1996-03       Impact factor: 4.016

5.  Cortical acetylcholine and processing capacity: effects of cortical cholinergic deafferentation on crossmodal divided attention in rats.

Authors:  J Turchi; M Sarter
Journal:  Brain Res Cogn Brain Res       Date:  1997-10

6.  ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine dihydrochloride]: II. A novel cholinergic channel modulator with effects on cognitive performance in rats and monkeys.

Authors:  M W Decker; A W Bannon; P Curzon; K L Gunther; J D Brioni; M W Holladay; N H Lin; Y Li; J F Daanen; J J Buccafusco; M A Prendergast; W J Jackson; S P Arneric
Journal:  J Pharmacol Exp Ther       Date:  1997-10       Impact factor: 4.030

7.  Cortical input to the basal forebrain.

Authors:  L Zaborszky; R P Gaykema; D J Swanson; W E Cullinan
Journal:  Neuroscience       Date:  1997-08       Impact factor: 3.590

8.  ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine]: I. A potent and selective cholinergic channel modulator with neuroprotective properties.

Authors:  J P Sullivan; D Donnelly-Roberts; C A Briggs; D J Anderson; M Gopalakrishnan; I C Xue; M Piattoni-Kaplan; E Molinari; J E Campbell; D G McKenna; D E Gunn; N H Lin; K B Ryther; Y He; M W Holladay; S Wonnacott; M Williams; S P Arneric
Journal:  J Pharmacol Exp Ther       Date:  1997-10       Impact factor: 4.030

9.  Nicotinic receptors in the rat prefrontal cortex: increase in glutamate release and facilitation of mediodorsal thalamo-cortical transmission.

Authors:  Y Gioanni; C Rougeot; P B Clarke; C Lepousé; A M Thierry; C Vidal
Journal:  Eur J Neurosci       Date:  1999-01       Impact factor: 3.386

10.  Mice deficient in the alpha7 neuronal nicotinic acetylcholine receptor lack alpha-bungarotoxin binding sites and hippocampal fast nicotinic currents.

Authors:  A Orr-Urtreger; F M Göldner; M Saeki; I Lorenzo; L Goldberg; M De Biasi; J A Dani; J W Patrick; A L Beaudet
Journal:  J Neurosci       Date:  1997-12-01       Impact factor: 6.167

View more
  65 in total

Review 1.  CNTRICS final animal model task selection: control of attention.

Authors:  C Lustig; R Kozak; M Sarter; J W Young; T W Robbins
Journal:  Neurosci Biobehav Rev       Date:  2012-06-06       Impact factor: 8.989

2.  Forebrain deletion of the vesicular acetylcholine transporter results in deficits in executive function, metabolic, and RNA splicing abnormalities in the prefrontal cortex.

Authors:  Benjamin Kolisnyk; Mohammed A Al-Onaizi; Pedro H F Hirata; Monica S Guzman; Simona Nikolova; Shahar Barbash; Hermona Soreq; Robert Bartha; Marco A M Prado; Vania F Prado
Journal:  J Neurosci       Date:  2013-09-11       Impact factor: 6.167

3.  Nicotinic α7 receptors enhance NMDA cognitive circuits in dorsolateral prefrontal cortex.

Authors:  Yang Yang; Constantinos D Paspalas; Lu E Jin; Marina R Picciotto; Amy F T Arnsten; Min Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-01       Impact factor: 11.205

4.  Monitoring cholinergic activity during attentional performance in mice heterozygous for the choline transporter: a model of cholinergic capacity limits.

Authors:  Giovanna Paolone; Caitlin S Mallory; Ajeesh Koshy Cherian; Thomas R Miller; Randy D Blakely; Martin Sarter
Journal:  Neuropharmacology       Date:  2013-08-16       Impact factor: 5.250

Review 5.  What do phasic cholinergic signals do?

Authors:  Martin Sarter; Cindy Lustig; Anne S Berry; Howard Gritton; William M Howe; Vinay Parikh
Journal:  Neurobiol Learn Mem       Date:  2016-02-18       Impact factor: 2.877

6.  Cholinergic control over attention in rats prone to attribute incentive salience to reward cues.

Authors:  Giovanna Paolone; Christopher C Angelakos; Paul J Meyer; Terry E Robinson; Martin Sarter
Journal:  J Neurosci       Date:  2013-05-08       Impact factor: 6.167

7.  Co-treatment with rivastigmine and idalopirdine reduces the propensity for falls in a rat model of falls in Parkinson's disease.

Authors:  Ajeesh Koshy Cherian; Aaron Kucinski; Ryan Wu; Inge E M de Jong; Martin Sarter
Journal:  Psychopharmacology (Berl)       Date:  2019-01-04       Impact factor: 4.530

Review 8.  Where attention falls: Increased risk of falls from the converging impact of cortical cholinergic and midbrain dopamine loss on striatal function.

Authors:  Martin Sarter; Roger L Albin; Aaron Kucinski; Cindy Lustig
Journal:  Exp Neurol       Date:  2014-05-05       Impact factor: 5.330

9.  Striatal cholinergic cell ablation attenuates L-DOPA induced dyskinesia in Parkinsonian mice.

Authors:  Lisa Won; Yunmin Ding; Pardeep Singh; Un Jung Kang
Journal:  J Neurosci       Date:  2014-02-19       Impact factor: 6.167

10.  Diminished trkA receptor signaling reveals cholinergic-attentional vulnerability of aging.

Authors:  Vinay Parikh; William M Howe; Ryan M Welchko; Sean X Naughton; Drew E D'Amore; Daniel H Han; Monika Deo; David L Turner; Martin Sarter
Journal:  Eur J Neurosci       Date:  2012-12-11       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.